Pateclizumab
Pateclizumab is a monoclonal antibody that was designed for the treatment of rheumatoid arthritis. It was developed by Genentech, a biotechnology company based in the United States. Pateclizumab targets the interleukin 6 (IL-6) pathway, which plays a crucial role in the inflammatory response that characterizes rheumatoid arthritis.
Mechanism of Action
Pateclizumab works by binding to the interleukin 6 receptor (IL-6R), thereby inhibiting the interaction between IL-6 and its receptor. This prevents the activation of the IL-6 pathway, which is known to contribute to the inflammation and joint damage seen in rheumatoid arthritis.
Clinical Trials
Pateclizumab has undergone Phase II clinical trials for the treatment of rheumatoid arthritis. The results of these trials showed that pateclizumab was well-tolerated and led to improvements in disease activity scores in patients with rheumatoid arthritis.
See Also
References
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
